Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy
Nature Genetics2009Vol. 41(12), pp. 1345–1349
Citations Over TimeTop 10% of 2009 papers
Colin J.D. Ross, Hagit Katzov-Eckert, Marie‐Pierre Dubé, Beth Brooks, Shahrad R. Rassekh, Amina Barhdadi, Yassamin Feroz-Zada, Henk Visscher, Andrew Brown, Michael Rieder, Paul Rogers, Michael Phillips, Bruce Carleton, Michael R. Hayden
Related Papers
- → Preemptive NUDT15 genotyping: redefining the management of patients with thiopurine-induced toxicity(2018)20 cited
- → Pharmacogenetics of Inflammatory Bowel Disease(2014)14 cited
- → Pharmacogenetic determinants of thiopurines in an Indian cohort(2020)8 cited
- → Prospects and Limits of Pharmacogenetics(2003)39 cited
- → Thiopurines for Inflammatory Bowel Disease: Role of Pharmacogenetics(2005)1 cited